Ποια είναι η τιμή για Hemagen Diagnostics, Inc. (HMGN)

Η τιμή για Hemagen Diagnostics, Inc. (HMGN) είναι $0.0002

Ποια είναι η κεφαλαιοποίηση αγοράς για Hemagen Diagnostics, Inc. (HMGN)

Η κεφαλαιοποίηση αγοράς για Hemagen Diagnostics, Inc. (HMGN) είναι $3.10K

Hemagen Diagnostics, Inc. (HMGN) Τιμή και Κεφαλαιοποίηση Αγοράς

Hemagen Diagnostics, Inc., a global biotechnology firm, specializes in delivering clinical diagnostic solutions for both human and animal health. The company designs, manufactures, and distributes the VIRGO product line, a series of human clinical immunoassays used for identifying autoimmune and infectious diseases, as well as acute phase proteins. Its comprehensive human diagnostic portfolio also encompasses Universal IFA components, various supplies, controls, calibrators, accessories, H-rotors, reagents, electrodes, equipment, and specialized assays covering conditions such as Chagas, acute phase proteins, and cytokines. For the veterinary market, Hemagen Diagnostics provides diagnostic equipment, reagents, consumables, accessories, and electrodes crucial for chemistry, hematology, and electrolyte analysis. The company reaches a diverse customer base, including laboratories, hospitals, and blood banks, through both direct sales and an extensive distribution network. Established in 1985, Hemagen Diagnostics maintains its headquarters in Columbia, Maryland.

Η τιμή για HMGN	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$347,314 $3.10K	NVDA	$5.383T	+173,656,756,674.19%
$286,034 $3.10K	AAPL	$4.434T	+143,016,944,485.81%
$268,212 $3.10K	GOOG	$4.157T	+134,106,067,430.65%
$236,343 $3.10K	MSFT	$3.663T	+118,171,639,803.23%
$186,531 $3.10K	AMZN	$2.891T	+93,265,444,912.90%

Η τιμή για HMGN

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$347,314 $3.10K